Accessibility statement

We want nueroenergizers.com to be usable by as many people as possible, including people who rely on assistive technology.

Our target

We aim to conform to the Web Content Accessibility Guidelines (WCAG) 2.1, Level AA. Accessibility is an ongoing effort and some content may not yet fully meet that standard.

What we have done

  • Semantic HTML with a single main heading per page and a logical heading order.
  • Landmark regions (header, nav, main, footer) and a “skip to content” link.
  • Visible keyboard focus indicators and full keyboard operability of navigation, buttons and disclosure widgets.
  • Text alternatives for images that convey information; decorative images are left unlabelled.
  • Colour combinations chosen to meet AA contrast ratios in both light and dark modes.
  • Responsive layout that reflows without horizontal scrolling down to small screens and supports browser zoom and larger text.
  • Respect for the operating-system “reduce motion” setting.
  • Captions/descriptions for figures, and tables that scroll within their own container rather than breaking the page.

Known limitations

  • External sites we link to (including the official product store and ClickBank) are outside our control and may not meet the same standard.
  • A few illustrative images have short alt text; the information they support is always given in the surrounding text as well.

Telling us about a problem

If you encounter an accessibility barrier on this site, please email us at contact@nueroenergizers.com or use the contact page. Describe the page, what you were trying to do, and the assistive technology or browser you were using. We aim to acknowledge reports within a few business days and to fix confirmed issues as quickly as we reasonably can.

Formal complaints

This site is operated as an independent publisher, not a government body. If you are in the United States and believe you have been unable to access information or services because of a disability, you may also wish to review your rights under the Americans with Disabilities Act (ADA) and Section 508 guidance published by the U.S. federal government.

Last reviewed: 2026-09-09.